. 2022 Sep 29;14(10):2085. doi: 10.3390/pharmaceutics14102085

Table 1.

Flux of BD and Cal from commercially available topical formulations determined through in vitro Franz diffusion cells. When the values were not tabulated, the flux is calculated as the slope of the permeation profile curve. NA: not available.

Formulation	Trade Name	Skin Source	Flux (ng/cm² h⁻¹)		Reference
Formulation	Trade Name	Skin Source	BD	Cal	Reference
Ointment	Daivonex^®	Pig	NA *	6.7 ± 0.4	[22]
Ointment	Diproderm^®	Pig	50 ± 9	NA *	[22]
Ointment	Generic product	Human	2.81 ± 0.28	0.23 ± 0.04	[35]
Ointment	Daivobet^®	Human	1.93 ± 0.29	0.13 ± 0.05	[35]
FoamOintment	Enstillar^®	Pig	-- *	0.005	Estimated from [27]
FoamOintment	--	Pig	-- *	0.002	Estimated from [27]
Oleogel/suspensionCream	--	Human	~34	~4	[31]
Oleogel/suspensionCream	Wynzora^®	Human	~68	~12	[31]

* below the limit of quantification.